Therini Bio Raises $39Million in Series A to Advance Neurodegenerative Pipeline
May 14, 2025
Angelini Ventures and Apollo Health Ventures join existing top-tier investor syndicate Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven